Neovivum
System-level prediction for precision medicine
Neovivum is a deep-tech biotechnology company developing AI-powered digital twin technology to model, simulate, and predict the behaviour of complex biological systems. Our work combines computational biology, artificial intelligence, systems modelling, and biomedical research to advance the future of precision medicine, drug development, and predictive healthcare
From Research to Innovation
Neovivum builds on more than a decade of scientific research, European collaborative projects, and technology development led by our founder and CEO, Prof. Igor Balaž. The company was established to translate pioneering research in computational biology and complex systems into technologies capable of transforming how diseases are understood and treated.
The Team Behind Neovivum
Our multidisciplinary team brings together expertise in biology, artificial intelligence, bioinformatics, systems modelling, software engineering, and innovation management. We work closely with leading academic, clinical, and industrial partners across Europe to advance the development of predictive biology and digital twin technologies.
Join Us
We are building technologies at the intersection of AI and biology and are always interested in connecting with talented researchers, engineers, and innovators who share our vision of transforming healthcare through predictive biology.